An open-label, in-use study assessing the warming sensation accompanying IFF Flavour 316282 and the acceptability and local tolerability of a syrup containing paracetamol and pseudoephedrine for the short-term treatment of symptoms of an upper respiratory tract infection. (16th March 2015)
- Record Type:
- Journal Article
- Title:
- An open-label, in-use study assessing the warming sensation accompanying IFF Flavour 316282 and the acceptability and local tolerability of a syrup containing paracetamol and pseudoephedrine for the short-term treatment of symptoms of an upper respiratory tract infection. (16th March 2015)
- Main Title:
- An open-label, in-use study assessing the warming sensation accompanying IFF Flavour 316282 and the acceptability and local tolerability of a syrup containing paracetamol and pseudoephedrine for the short-term treatment of symptoms of an upper respiratory tract infection
- Authors:
- Furcha, Rowland
Monnet, Joëlle - Abstract:
- Objective: The primary objective was to assess the warming sensation caused by IFF Flavour 316282 in a syrup used for short-term treatment by patients suffering from nasal congestion and mild to moderate body pain, headache, fever or sore throat associated with an upper respiratory tract infection. Methods: A single cohort, single treatment arm, open-label study. Subjects received one 30 mL dose of syrup containing IFF Flavour 316282, paracetamol and pseudoephedrine and recorded onset and disappearance of any warming sensation in the mouth/throat. Subjects' assessments of strength and appeal of the sensation, taste, texture and acceptability of the product was investigated using questionnaires. Results: A total of 56 subjects were included; 53 (94.6%) experienced a warming sensation. The median duration of the warming sensation was 114 s (95% confidence interval: 87–120 s). All subjects rated the syrup as excellent, good or fair for treating their symptoms; 100% and 94.6% of subjects respectively described texture and taste as excellent, good or fair. There were no safety concerns, and the syrup was well tolerated. Most subjects liked the warming sensation. Conclusions: IFF Flavour 316282 in a syrup for treatment of upper respiratory tract infection symptoms is associated with a warming sensation. The syrup is well tolerated, safe and palatable.
- Is Part Of:
- SAGE open medicine. Volume 3(2015)
- Journal:
- SAGE open medicine
- Issue:
- Volume 3(2015)
- Issue Display:
- Volume 3, Issue 2015 (2015)
- Year:
- 2015
- Volume:
- 3
- Issue:
- 2015
- Issue Sort Value:
- 2015-0003-2015-0000
- Page Start:
- Page End:
- Publication Date:
- 2015-03-16
- Subjects:
- IFF flavour 316282 -- flavouring agent -- warming -- upper respiratory tract infection -- nasal congestion -- decongestant -- syrup
Medicine -- Periodicals
610.5 - Journal URLs:
- http://smo.sagepub.com/ ↗
http://www.uk.sagepub.com/home.nav ↗ - DOI:
- 10.1177/2050312115575937 ↗
- Languages:
- English
- ISSNs:
- 2050-3121
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9603.xml